Clinical Trials

Our clinical trials team actively participate in many international clinical trials. 

LIGHTHOUSE II (In Collaboration with TRICALS) – Randomised Double-blind Placebo-controlled Phase 3 Trial Of Triumeq In Amyotrophic Lateral Sclerosis- Enrollment to Open.

CARDINALS– A Phase 2, Randomized, Double-blind, Placebocontrolled, Parallel Study To Assess The Efficacy, safety, Tolerability, Pk, And Biomarker Effects Of ptc857 In Adult Subjects With Amyotrophic Lateral sclerosis- Enrollment Closed.

DAZALS- A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Evaluating Safety and Efficacy of CORT113176 (Dazucorilant) in Patients with Amyotrophic Lateral Sclerosis- Enrollment Closed.